CDLX
Cardlytics, Inc.
CDLX trails on the overall score without a compensating advantage in the available component scores.
TMUS
T-Mobile US, Inc.
TMUS has the edge over CDLX overall, supported by lower modeled downside and stronger valuation.
CDLX Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Under pressure | |
| Unavailable |
CDLX's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
TMUS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Strong |
TMUS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
CDLX PE Valuation
CDLX has no meaningful PE right now: it lost money over the past year.
TMUS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $171 | — |
| Current | 16x | $171 | — |
| Cheap | 21x | $218 | +27% |
| Fair | 26x | $274 | +60% |
| Expensive | 56x | $581 | +240% |
Historical ranges are pointers, not guarantees.
TMUS's PE is in its cheap range at 16x. If earnings grow as analysts expect, today's price would be 13x next year's earnings.
CDLX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Decline | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect CDLX's losses to shrink, with revenue declining. However, they disagree widely on these estimates.
TMUS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
TMUS has the edge over CDLX on the outlook, with more favorable revenue expectations.
CDLX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$6.42 | +$15.18 |
| Q2 2026 | -$18.50 | +$18.50 |
| Q1 2026 | -$17.72 | +$18.38 |
| Q4 2025 | -$19.50 | +$19.60 |
| Q3 2025 | -$21.60 | +$40.45 |
| Q2 2025 | -$37.00 | +$2.35 |
| Q1 2025 | -$36.10 | +$9.05 |
| Q4 2024 | -$39.10 | -$3.55 |
CDLX is still losing money, but far less than before: $6.42 per share over the past year, against $145.30 at its worst in early 2023.
TMUS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.49 | +30% |
| Q3 2026 | $10.37 | -0.2% |
| Q2 2026 | $9.56 | -9.7% |
| Q1 2026 | $9.41 | -8.1% |
| Q4 2025 | $9.72 | +0.6% |
| Q3 2025 | $10.39 | +18% |
| Q2 2025 | $10.59 | +33% |
| Q1 2025 | $10.24 | +39% |
| Q4 2024 | $9.66 | +39% |
TMUS has the edge over CDLX on earnings quality, reporting a profit while its opponent remains loss making.
CDLX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $32.9M | -37% |
| Q2 2026 | $36.9M | -42% |
| Q1 2026 | $34.3M | -45% |
| Q4 2025 | $56.1M | -24% |
| Q3 2025 | $52M | -22% |
| Q2 2025 | $63.2M | -9.2% |
| Q1 2025 | $61.9M | -8.4% |
| Q4 2024 | $74M | -17% |
CDLX's revenue has slid since its 2021 peak: $33M last quarter, down 37% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -16% | +116 points |
| Q2 2026 | -15% | +5.5 points |
| Q1 2026 | -24% | -1.4 points |
| Q4 2025 | -11% | +0.4 points |
| Q3 2025 | -132% | +89 points |
| Q2 2025 | -20% | +2.5 points |
| Q1 2025 | -23% | +11 points |
| Q4 2024 | -11% | +104 points |
CDLX's operating margin was −16% last quarter, up 116 points from the same quarter a year ago.
TMUS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $23.6B | +7.4% |
| Q2 2026 | $22.8B | +7.9% |
| Q1 2026 | $23.1B | +11% |
| Q4 2025 | $24.3B | +11% |
| Q3 2025 | $22B | +8.9% |
| Q2 2025 | $21.1B | +6.9% |
| Q1 2025 | $20.9B | +6.6% |
| Q4 2024 | $21.9B | +6.8% |
TMUS has the edge over CDLX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 24% | +3.4 points |
| Q2 2026 | 24% | -0.6 points |
| Q1 2026 | 19% | -3.5 points |
| Q4 2025 | 15% | -5.6 points |
| Q3 2025 | 21% | -3.2 points |
| Q2 2025 | 25% | +1.3 points |
| Q1 2025 | 23% | +2.6 points |
| Q4 2024 | 21% | +4 points |
TMUS has the edge over CDLX on profitability, with a higher operating margin.
CDLX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$5.9M | -439% |
| Q2 2026 | -$8.6M | -1052% |
| Q1 2026 | -$5.7M | +$1.2M |
| Q4 2025 | $13M | +355% |
| Q3 2025 | $1.7M | +99% |
| Q2 2025 | $903K | -78% |
| Q1 2025 | -$6.8M | +$11.4M |
| Q4 2024 | $2.9M | +7.4% |
CDLX's free cash flow was −$7M over the past year, against −$1M the year before.
TMUS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +5.3% |
| Q2 2026 | $4.8B | +4.4% |
| Q1 2026 | $4.6B | +4.6% |
| Q4 2025 | $4.2B | +25% |
| Q3 2025 | $4.8B | +15% |
| Q2 2025 | $4.6B | +32% |
| Q1 2025 | $4.4B | +79% |
| Q4 2024 | $3.3B | +2% |
TMUS has the edge over CDLX on cash generation, producing positive trailing cash flow while its opponent burns cash.
CDLX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.5% | +143K shares |
| 1 year | +10% | +553K shares |
| 3 years | +55% | +2.1M shares |
| 5 years | +116% | +3.2M shares |
| Available history | +149% | +3.5M shares |
CDLX has 6M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2025 | — |
| Q4 2024 | $309,000 |
| Q3 2024 | $119,000 |
| Q4 2023 | — |
| Q3 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
TMUS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -10.8M shares |
| 1 year | -4.9% | -55M shares |
| 3 years | -8.8% | -103M shares |
| 5 years | -15% | -182M shares |
| Available history | +24% | +207M shares |
TMUS has the edge over CDLX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.4B |
| Q2 2026 | $2.3B |
| Q1 2026 | $4.8B |
| Q4 2025 | $2.4B |
| Q3 2025 | $2.5B |
| Q2 2025 | $2.6B |
| Q1 2025 | $2.5B |
| Q4 2024 | $4.7B |
TMUS spent $12B buying back its own shares over the past year, down 1.7% from the year before.
CDLX Net Leverage
CDLX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
TMUS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.0x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | 2.5x | Moderate |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | 2.4x | Moderate |
TMUS's net debt is less than a year of its operating earnings (EBITDA).
CDLX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.0 | Oversold |
| Stochastic | 5.9 | Oversold |
CDLX's weekly RSI is 28 (oversold) and its Stochastic is 6 (oversold).
TMUS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.9 | Neutral |
| Stochastic | 42.1 | Neutral |
TMUS's weekly RSI is 48 (neutral) and its Stochastic is 42 (neutral).
CDLX PE vs Communication Services Sector
CDLX has no meaningful PE right now: it lost money over the past year.
TMUS PE vs Communication Services Sector
| Metric | TMUS | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 16x | Same PE |
| PE % | 1 | 26 | 25 pts below |
TMUS is trading at 16x earnings, in line with the Communication Services sector's median of 16x.
CDLX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.11 | 32% below |
| 20 week MA | $3.25 | 56% below |
| 50 week MA | $6.64 | 78% below |
| 100 week MA | $13.8 | 90% below |
| 200 week MA | $46.7 | 97% below |
CDLX is in a downtrend: it's below all five of its weekly moving averages, and 97% below its 200-week average.
TMUS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $159.1 | 7.5% above |
| 20 week MA | $172.0 | 0.5% below |
| 50 week MA | $187.8 | 8.9% below |
| 100 week MA | $212.9 | 20% below |
| 200 week MA | $188.7 | 9.4% below |
TMUS has the edge over CDLX on trend strength, trading above more of its moving averages.
CDLX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $649.6 | $1,430.2 | +120% |
| 2021 | $1,430.2 | $662.5 | -54% |
| 2022 | $662.5 | $48.2 | -93% |
| 2023 | $48.2 | $92.1 | +91% |
| 2024 | $92.1 | $37.3 | -60% |
| 2025 | $37.3 | $11.9 | -68% |
| 2026 YTD | $11.9 | $1.43 | -88% |
CDLX's yearly returns have swung widely, from +120% in 2020 to −93% in 2022. It's down 88% so far in 2026.
TMUS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $77.2 | $132.9 | +72% |
| 2021 | $132.9 | $119.9 | -9.8% |
| 2022 | $119.9 | $140.0 | +17% |
| 2023 | $140.0 | $160.3 | +15% |
| 2024 | $160.3 | $223.0 | +39% |
| 2025 | $223.0 | $201.0 | -9.9% |
| 2026 YTD | $201.0 | $171.0 | -15% |
TMUS has the edge over CDLX on returns for 2026, with the stronger performance.